Steen Gammeltoft,3
Pietro Formisano,1 and
Francesco Beguinot1*
Dipartimento di Biologia e Patologia Cellulare e Molecolare & Istituto di Endocrinologia ed Oncologia Sperimentale del CNR, Università degli Studi di Napoli Federico II, Naples, Italy,1 Istituto di Biostrutture e Bioimmagini del CNR, Naples, Italy,2 Department of Clinical Biochemistry, Glostrup Hospital, DK 2600 Glostrup, Denmark3
Received 31 July 2005/ Accepted 19 September 2005
In
L6 myoblasts, insulin receptors with deletion of the C-terminal 43
amino acids (IR
43) exhibited normal
autophosphorylation and IRS-1/2 tyrosine phosphorylation. The L6 cells
expressing IR
43 (L6IR
43) also
showed no insulin effect on glucose uptake and glycogen synthase,
accompanied by a >80% decrease in insulin induction of
3-phosphoinositide-dependent protein kinase 1 (PDK-1) activity and
tyrosine phosphorylation and of protein kinase B (PKB) phosphorylation
at Thr308. Insulin induced the phosphatidylinositol 3
kinase-dependent coprecipitation of PDK-1 with wild-type IR
(IRWT), but not IR
43. Based on overlay
blotting, PDK-1 directly bound IRWT, but not
IR
43. Insulin-activated IRWT, and not
IR
43, phosphorylated PDK-1 at tyrosines 9, 373, and
376. The IR C-terminal 43-amino-acid peptide (C-terminal peptide)
inhibited in vitro PDK-1 tyrosine phosphorylation by the IR.
Tyr
Phe substitution prevented this inhibitory action. In the
L6hIR cells, the C-terminal peptide
coprecipitated with PDK-1 in an insulin-stimulated fashion. This
peptide simultaneously impaired the insulin effect on PDK-1
coprecipitation with IRWT, on PDK-1 tyrosine
phosphorylation, on PKB phosphorylation at Thr308, and on
glucose uptake. Upon insulin exposure, PDK-1 membrane persistence was
significantly reduced in L6IR
43 compared to control
cells. In L6 cells expressing IRWT, the C-terminal peptide
also impaired insulin-dependent PDK-1 membrane persistence. Thus, PDK-1
directly binds to the insulin receptor, followed by PDK-1 activation
and insulin metabolic
effects.
Present
address: Mammalian Cell Technology, Novo Nordisk A/S, DK 2880
Bagsvaerd, Denmark.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|